FR13C0051I1 - Administration d'antipsychotiques par inhalation - Google Patents

Administration d'antipsychotiques par inhalation

Info

Publication number
FR13C0051I1
FR13C0051I1 FR13C0051C FR13C0051C FR13C0051I1 FR 13C0051 I1 FR13C0051 I1 FR 13C0051I1 FR 13C0051 C FR13C0051 C FR 13C0051C FR 13C0051 C FR13C0051 C FR 13C0051C FR 13C0051 I1 FR13C0051 I1 FR 13C0051I1
Authority
FR
France
Prior art keywords
antipsychotic
inhalation
composition
mammal
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR13C0051C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alexza Pharmaceuticals Inc
Original Assignee
Alexza Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexza Pharmaceuticals Inc filed Critical Alexza Pharmaceuticals Inc
Publication of FR13C0051I1 publication Critical patent/FR13C0051I1/fr
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/4211,3-Oxazoles, e.g. pemoline, trimethadione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/423Oxazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/49Cinchonan derivatives, e.g. quinine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/501Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/55171,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/06Inhaling appliances shaped like cigars, cigarettes or pipes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24HEATING; RANGES; VENTILATING
    • F24VCOLLECTION, PRODUCTION OR USE OF HEAT NOT OTHERWISE PROVIDED FOR
    • F24V30/00Apparatus or devices using heat produced by exothermal chemical reactions other than combustion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A61M11/042Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8206Internal energy supply devices battery-operated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Otolaryngology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Mechanical Engineering (AREA)
  • Combustion & Propulsion (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
FR13C0051C 2001-05-24 2013-08-19 Administration d'antipsychotiques par inhalation Active FR13C0051I1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29420301P 2001-05-24 2001-05-24
US31747901P 2001-09-05 2001-09-05
PCT/US2002/016118 WO2002094236A1 (fr) 2001-05-24 2002-05-20 Administration d'antipsychotiques par inhalation

Publications (1)

Publication Number Publication Date
FR13C0051I1 true FR13C0051I1 (fr) 2013-09-27

Family

ID=30772632

Family Applications (1)

Application Number Title Priority Date Filing Date
FR13C0051C Active FR13C0051I1 (fr) 2001-05-24 2013-08-19 Administration d'antipsychotiques par inhalation

Country Status (16)

Country Link
US (75) US6737042B2 (fr)
EP (14) EP1392262A1 (fr)
JP (7) JP2005503425A (fr)
AT (11) ATE462420T1 (fr)
AU (3) AU2002314784A1 (fr)
BE (1) BE2013C054I2 (fr)
CA (7) CA2446904A1 (fr)
DE (4) DE60235851D1 (fr)
DK (1) DK1389098T3 (fr)
ES (5) ES2341594T3 (fr)
FR (1) FR13C0051I1 (fr)
MX (2) MXPA03010703A (fr)
NZ (6) NZ529422A (fr)
PL (3) PL363996A1 (fr)
PT (2) PT1389098E (fr)
WO (1) WO2002094236A1 (fr)

Families Citing this family (376)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030203036A1 (en) * 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US7087215B2 (en) * 1998-12-21 2006-08-08 Generex Pharmaceuticals Incorporated Methods of administering and enhancing absorption of pharmaceutical agents
US7258850B2 (en) * 1999-05-04 2007-08-21 Aradigm Corporation Methods and compositions for treating erectile dysfunction
PT1218049E (pt) * 1999-07-12 2007-01-31 Capnia Inc Aparelho para o alívio de dores de cabeça, rinite e outros padecimentos comuns
US20060172017A1 (en) 1999-11-08 2006-08-03 Capnia, Incorporated Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces
US20070039615A1 (en) * 1999-11-08 2007-02-22 Capnia, Incorporated Methods and apparatus for treating rhinitis
WO2001036018A2 (fr) * 1999-11-08 2001-05-25 Capnia Incorporated Methode et appareil de co-application de gaz et de medicaments pour potentialiser leur action soulageant les maux de tete, l'angine et d'autres maux
US6888106B2 (en) * 2000-04-07 2005-05-03 Ibiden Co., Ltd. Ceramic heater
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
WO2002009669A2 (fr) * 2000-08-01 2002-02-07 Inhale Therapeutic Systems, Inc. Appareil et procede de production de particules a distribution granulometrique etroite et particules ainsi obtenues
US20020169507A1 (en) 2000-12-14 2002-11-14 David Malone Interbody spine fusion cage
SE0101204D0 (sv) * 2001-04-04 2001-04-04 Siemens Elema Ab Heating device for respiration gas
US7090830B2 (en) * 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
WO2002094242A1 (fr) 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Administration de rizatriptan ou de zolmitriptan par voie d'inhalation
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
EP1392262A1 (fr) * 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Administration d'esters medicamenteux par inhalation
US20030051728A1 (en) * 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7078016B2 (en) * 2001-11-21 2006-07-18 Alexza Pharmaceuticals, Inc. Delivery of caffeine through an inhalation route
US6805853B2 (en) 2001-11-09 2004-10-19 Alexza Molecular Delivery Corporation Delivery of diazepam through an inhalation route
NZ529417A (en) 2001-05-24 2006-11-30 Alexza Pharmaceuticals Inc Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
CA2462576A1 (fr) * 2001-11-21 2003-06-03 Alexza Molecular Delivery Corporation Substrats a cellules ouvertes pour administration de medicaments
US7523065B2 (en) * 2001-12-12 2009-04-21 Asset Trust, Inc. Risk transfer supply chain system
GB2384184B (en) * 2002-01-10 2005-01-12 Aea Technology Plc Cannabis aerosol
US7582284B2 (en) * 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
GB0216562D0 (en) * 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
AU2003239433A1 (en) * 2002-05-13 2003-11-11 Alexza Molecular Delivery Corporation Delivery of drug amines through an inhalation route
US20060193788A1 (en) * 2002-11-26 2006-08-31 Hale Ron L Acute treatment of headache with phenothiazine antipsychotics
MXPA04012347A (es) * 2002-06-10 2005-02-25 Wyeth Corp Nueva sal formiato de o-desmetilvenlafaxina.
DE10234165B4 (de) * 2002-07-26 2008-01-03 Advanced Micro Devices, Inc., Sunnyvale Verfahren zum Füllen eines Grabens, der in einem Substrat gebildet ist, mit einem isolierenden Material
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
US7644715B2 (en) * 2002-10-31 2010-01-12 Cooltouch, Incorporated Restless leg syndrome treatment
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
CN101371843B (zh) * 2002-11-26 2012-09-26 艾利斯达医药品公司 洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用
CA2507158A1 (fr) * 2002-11-26 2004-06-10 Alexza Molecular Delivery Corporation Traitement de la migraine sous antipsychotiques administres par inhalation
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
JP2006516963A (ja) * 2003-02-04 2006-07-13 クリサリス テクノロジーズ インコーポレイテッド エアロゾル製剤及びブスピロン、ブプレノルフィン、トリアゾラム、シクロベンザプリン及びゾルピデムのエアロゾル送出
WO2005082369A1 (fr) * 2003-02-28 2005-09-09 Delex Therapeutics Inc. Systeme d'administration d'un opioide
MXPA05009179A (es) * 2003-02-28 2006-03-08 Delex Therapeutics Inc Sistema para suministro de opioides.
US7648981B2 (en) 2003-02-28 2010-01-19 Ym Biosciences Inc. Opioid delivery system
US7648982B2 (en) 2003-02-28 2010-01-19 Ym Biosciences Inc. Opioid delivery system
BRPI0409380A (pt) * 2003-04-14 2006-04-18 Vectura Ltd composições farmacêuticas
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
US20040234914A1 (en) * 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Percussively ignited or electrically ingnited self-contained heating unit and drug-supply unit employing same
GB0314149D0 (en) * 2003-06-18 2003-07-23 Generics Uk Ltd Novel amorphous forms
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
CN2718561Y (zh) * 2003-07-11 2005-08-17 艾康生物技术(杭州)有限公司 用于取样签的保护套
NZ527142A (en) * 2003-07-23 2006-03-31 Douglas Pharmaceuticals Ltd A stable suspension formulation
US20050042177A1 (en) * 2003-07-23 2005-02-24 Elan Pharma International Ltd. Novel compositions of sildenafil free base
US20050037506A1 (en) * 2003-08-04 2005-02-17 Alexza Molecular Delivery Corporation Methods of determining film thicknesses for an aerosol delivery article
ATE470468T1 (de) * 2003-08-04 2010-06-15 Alexza Pharmaceuticals Inc Substrate für eine medikamentenverabreichungsvorrichtung und verfahren zur bereitung
AU2004272077A1 (en) * 2003-09-10 2005-03-24 Map Pharmaceuticals, Inc. Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
RU2362551C2 (ru) * 2003-09-15 2009-07-27 Вектура Лимитед Фармацевтические композиции для лечения преждевременной эякуляции при помощи легочной ингаляции
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
CN1305266C (zh) * 2003-12-19 2007-03-14 深圳国人通信有限公司 基于嵌入式系统的无线局域网接入点设备
US20050171088A1 (en) * 2004-01-30 2005-08-04 Astrazeneca Ab Treatment of psychoses with dibenzothiazepine antipsychotic
US20050256553A1 (en) * 2004-02-09 2005-11-17 John Strisower Method and apparatus for the treatment of respiratory and other infections using ultraviolet germicidal irradiation
JP4440966B2 (ja) * 2004-03-04 2010-03-24 ユーティーシダカントンシュンヨウシャンゴンシ 無線基地局におけるロード共有方法及びシステム
US7422224B2 (en) * 2004-04-13 2008-09-09 Kimir Seatpost Adjustable bicycle seat post assembly
US7402777B2 (en) * 2004-05-20 2008-07-22 Alexza Pharmaceuticals, Inc. Stable initiator compositions and igniters
US7540286B2 (en) * 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US20100006092A1 (en) * 2004-08-12 2010-01-14 Alexza Pharmaceuticals, Inc. Aerosol Drug Delivery Device Incorporating Percussively Activated Heat Packages
US20060039869A1 (en) * 2004-08-17 2006-02-23 Daniel Wermeling Intranasal delivery of antipsychotic drugs
WO2006044421A2 (fr) * 2004-10-12 2006-04-27 Alexza Pharmaceuticals, Inc. Administration d'un medicament a action rapide, sans danger pour le systeme cardiovasculaire
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
AU2005315390B2 (en) * 2004-12-16 2011-10-27 Cipla Limited Process for the preparation of pantoprazole sodium
US20060130829A1 (en) * 2004-12-20 2006-06-22 Sexton Douglas A Inhalation device
US7827983B2 (en) * 2004-12-20 2010-11-09 Hewlett-Packard Development Company, L.P. Method for making a pharmaceutically active ingredient abuse-prevention device
CA2605473C (fr) * 2005-04-21 2013-10-29 Medichem, S.A. Procede de fabrication de quetiapine et de fumarate de quetiapine
US8062901B2 (en) * 2005-04-30 2011-11-22 Alere Switzerland Gmbh Devices and methods for sample collection and analysis
US20090117660A1 (en) * 2005-04-30 2009-05-07 Oakville Hong Kong Co., Limited Devices and methods for sample collection and analysis
US7241805B2 (en) 2005-06-27 2007-07-10 Biovail Laboratories, Inc. Modified release formulations of a bupropion salt
BRPI0615972A2 (pt) 2005-07-29 2011-05-31 Concert Pharmaceuticals Inc composto isolado, mistura, composição, item de manufatura, uso de um composto, método para determinar a concentração do composto em uma amostra biológica, kit de diagnóstico e método para avaliar a estabilidade metabólica de um composto
WO2007033239A2 (fr) * 2005-09-13 2007-03-22 Elan Pharma International, Limited Formulations nanoparticulaires de tadalafil
US20070092401A1 (en) * 2005-10-26 2007-04-26 Feier Liao Devices and methods for sample collection and analysis
JP5478070B2 (ja) * 2005-12-01 2014-04-23 ヴェイポア エルエルシー 改良された毛管力蒸発装置
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252328B2 (en) 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252329B2 (en) * 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8357114B2 (en) * 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8202535B2 (en) * 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
EP1984049A1 (fr) 2006-01-19 2008-10-29 Optinose AS Administration nasale
US20070183351A1 (en) * 2006-02-03 2007-08-09 Motorola, Inc. Method and apparatus for providing service in a multi-ran communication network
WO2007123945A2 (fr) * 2006-04-21 2007-11-01 Aradigm Corporation Dispositif monodose de distribution intrapulmonaire de médicaments
US7909033B2 (en) 2006-05-03 2011-03-22 Comedica Incorporated Breathing treatment apparatus
US8536445B2 (en) * 2006-06-02 2013-09-17 Emcore Solar Power, Inc. Inverted metamorphic multijunction solar cells
US20070299687A1 (en) * 2006-06-23 2007-12-27 Pamela Palmer Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
US8051854B2 (en) * 2006-09-15 2011-11-08 Comedica Incorporated Continuous high-frequency oscillation breathing treatment apparatus
US20090270438A1 (en) * 2006-10-18 2009-10-29 Clive Booles Novel compositions and formulations
GB0620661D0 (en) * 2006-10-18 2006-11-29 Pharmasol Ltd Novel compounds
US20080102097A1 (en) * 2006-10-31 2008-05-01 Zanella John M Device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent
US8279765B2 (en) * 2006-11-13 2012-10-02 Motorola Solutions, Inc. Method and apparatus for interworking in an inter-technology network
US20080154374A1 (en) * 2006-12-20 2008-06-26 Robert David Labrom Joint implant and a surgical method associated therewith
WO2008080170A1 (fr) * 2006-12-22 2008-07-03 Alexza Pharmaceuticals, Inc. Compositions aérosol de médicament mixte
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
KR20160106200A (ko) * 2007-02-11 2016-09-09 맵 파마슈티컬스, 인코포레이티드 부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 dhe의 치료적 투여 방법
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
WO2008115442A1 (fr) 2007-03-16 2008-09-25 Concert Pharmceuticals, Inc. Inhibiteurs de protéine de transfert d'ester de cholestérol
WO2008116165A2 (fr) * 2007-03-21 2008-09-25 Next Safety, Inc. Procédés et systèmes d'administration d'une médication par inhalation
US20080261926A1 (en) * 2007-04-02 2008-10-23 Liu Julie F Pharmaceutical Calcimimetics
GB2448183A (en) * 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
WO2008124585A1 (fr) * 2007-04-06 2008-10-16 Board Of Governors For Higher Education, State Of Rhode Island And Providence Planations Abaissement des niveaux de protéines associées à la maladie d'alzheimer par interruption de la transcription génique au moyen d'une petite molécule
WO2008128166A1 (fr) * 2007-04-13 2008-10-23 Concert Pharmaceuticals Inc. Dérivés deutériés de composés 4-(6-fluoro-1,2-benzisoxazol-3-yl) pipéridine
KR20100105802A (ko) * 2007-04-19 2010-09-29 콘서트 파마슈티컬즈, 인크. 중수소화된 모르폴리닐 화합물
EP2152689B1 (fr) 2007-04-25 2013-01-02 Concert Pharmaceuticals Inc. Analogues de cilostazol
DK2357183T3 (en) 2007-05-01 2015-09-07 Concert Pharmaceuticals Inc Morphinanforbindelser
AU2008247805A1 (en) 2007-05-01 2008-11-13 Concert Pharmaceuticals Inc. Naphthyl(ethyl) acetamides
EP2345653B1 (fr) * 2007-05-01 2012-12-26 Concert Pharmaceuticals Inc. Composés de morphine
MX341177B (es) 2007-05-01 2016-08-10 Concert Pharmaceuticals Inc Compuestos de morfina.
WO2008141021A1 (fr) * 2007-05-08 2008-11-20 Concert Pharmaceuticals, Inc. Dérivés deutérés de composés de tétrahydrotriazolopyrazine et leur utilisation en tant qu'inhibiteurs de la dpp-iv
US9050434B2 (en) * 2007-05-18 2015-06-09 Comedica Incorporated Lung therapy device
RU2448958C2 (ru) 2007-06-12 2012-04-27 Консерт Фармасьютикалз, Инк. Производные азапептидов
US7687509B2 (en) * 2007-07-09 2010-03-30 Concert Pharmaceuticals Inc. Pyrimidinecarboxamide derivatives
US8442390B2 (en) * 2007-08-29 2013-05-14 Philip Morris Usa Inc. Pulsed aerosol generation
EP2200997B9 (fr) 2007-09-13 2016-01-13 Concert Pharmaceuticals Inc. Synthèse de benzodioxoles deutériés
US8470360B2 (en) * 2008-04-18 2013-06-25 Warsaw Orthopedic, Inc. Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
US20090104964A1 (en) * 2007-10-17 2009-04-23 Igt Gaming system, gaming device and gaming method providing player physical activation of the symbol generator
WO2009051782A1 (fr) * 2007-10-18 2009-04-23 Concert Pharmaceuticals Inc. Étravirine deutérée
GB0721394D0 (en) * 2007-10-31 2007-12-12 Vectura Group Plc Compositions for trating parkinson's disease
US20090162421A1 (en) * 2007-12-21 2009-06-25 Paz Arzneimittel-Entwicklungsgesellschaft Mbh Drugs as well as their production and use in the treatment of pain-associated neuropathies
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CN101983058A (zh) * 2008-02-05 2011-03-02 克莱拉有限公司 缓解抑郁症或改善认知的组合物和方法
EP2247330B1 (fr) 2008-02-07 2017-09-20 The University of Washington Dispositif aérosol périphérique
EA019088B1 (ru) 2008-02-29 2014-01-30 Консерт Фармасьютикалз, Инк. Замещенные производные дейтерированных ксантинов и их применение
KR20150065941A (ko) 2008-03-06 2015-06-15 아나코르 파마슈티칼스 인코포레이티드 소염제로써 붕소가 함유된 소분자
US8201752B2 (en) * 2008-03-10 2012-06-19 Vapore, Inc. Low energy vaporization of liquids: apparatus and methods
US9132085B2 (en) 2008-04-18 2015-09-15 Warsaw Orthopedic, Inc. Compositions and methods for treating post-operative pain using clonidine and bupivacaine
US20090263489A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US8956641B2 (en) * 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of inflammatory diseases
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US8883768B2 (en) * 2008-04-18 2014-11-11 Warsaw Orthopedic, Inc. Fluocinolone implants to protect against undesirable bone and cartilage destruction
US20090263451A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain
US20090264489A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
US20090264477A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc., An Indiana Corporation Beta adrenergic receptor agonists for treatment of pain and/or inflammation
US8946277B2 (en) 2008-04-18 2015-02-03 Warsaw Orthopedic, Inc. Clonidine formulations in a biodegradable polymer carrier
US9072727B2 (en) 2008-04-18 2015-07-07 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of degenerative disc disease
US8557273B2 (en) * 2008-04-18 2013-10-15 Medtronic, Inc. Medical devices and methods including polymers having biologically active agents therein
US9610243B2 (en) 2008-04-18 2017-04-04 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US9132119B2 (en) * 2008-04-18 2015-09-15 Medtronic, Inc. Clonidine formulation in a polyorthoester carrier
US8722079B2 (en) * 2008-04-18 2014-05-13 Warsaw Orthopedic, Inc. Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
US8629172B2 (en) * 2008-04-18 2014-01-14 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising clonidine
US8420114B2 (en) * 2008-04-18 2013-04-16 Warsaw Orthopedic, Inc. Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
US9282927B2 (en) 2008-04-24 2016-03-15 Invention Science Fund I, Llc Methods and systems for modifying bioactive agent use
US20100017001A1 (en) * 2008-04-24 2010-01-21 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US9649469B2 (en) 2008-04-24 2017-05-16 The Invention Science Fund I Llc Methods and systems for presenting a combination treatment
US9449150B2 (en) 2008-04-24 2016-09-20 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US9662391B2 (en) 2008-04-24 2017-05-30 The Invention Science Fund I Llc Side effect ameliorating combination therapeutic products and systems
US9560967B2 (en) 2008-04-24 2017-02-07 The Invention Science Fund I Llc Systems and apparatus for measuring a bioactive agent effect
CA2765190C (fr) * 2008-05-27 2016-07-19 The University Of Melbourne Procedes de traitement de mammiferes souffrant de dysfonctionnements de la trompe d'eustache
US7845277B2 (en) * 2008-05-28 2010-12-07 Autoliv Asp, Inc. Header assembly
US20110160253A1 (en) * 2008-05-28 2011-06-30 Harbeson Scott L Deuterated tizanidine
US20100221221A1 (en) * 2008-08-12 2010-09-02 Concert Pharmaceuticals Inc. N-phenyl-2-pyrimidineamine derivatives
US20110190323A1 (en) * 2008-08-28 2011-08-04 President And Fellows Of Harvard College Cortistatin analogues and syntheses thereof
US7834295B2 (en) 2008-09-16 2010-11-16 Alexza Pharmaceuticals, Inc. Printable igniters
US20100065052A1 (en) * 2008-09-16 2010-03-18 Alexza Pharmaceuticals, Inc. Heating Units
CN102197037B (zh) 2008-09-19 2015-02-18 康塞特医药品公司 吗啡喃(morphinan)化合物
US20100098746A1 (en) * 2008-10-20 2010-04-22 Warsaw Orthopedic, Inc. Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
PT2397158T (pt) 2008-10-30 2016-07-07 Concert Pharmaceuticals Inc Combinação de compostos de morfinano e antidepressivo para o tratamento de afeto pseudobulbar
EP2397159A3 (fr) 2008-10-30 2012-02-22 Concert Pharmaceuticals, Inc. Combinaison de composés de morphinane et d' antidépresseur pour le traitement de la douleur incurable et chronique
US8198268B2 (en) * 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
AU2009311645C1 (en) 2008-11-04 2014-10-02 Acer Therapeutics Inc. CXCR4 receptor compounds
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
US20100196286A1 (en) * 2008-12-01 2010-08-05 Armer Thomas A Inhalation delivery methods and devices
US8822546B2 (en) * 2008-12-01 2014-09-02 Medtronic, Inc. Flowable pharmaceutical depot
US20110313004A1 (en) 2008-12-04 2011-12-22 Concert Pharmaceuticals, Inc. Deuterated pyridinones
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
US20100168525A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100168602A1 (en) * 2008-12-30 2010-07-01 Searete Llc Methods and systems for presenting an inhalation experience
US20100163025A1 (en) * 2008-12-30 2010-07-01 Searete Llc Methods and systems for presenting an inhalation experience
US20100168529A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100163036A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US8712794B2 (en) * 2008-12-30 2014-04-29 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US20100163034A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100163033A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US8738395B2 (en) * 2008-12-30 2014-05-27 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US20100169260A1 (en) * 2008-12-30 2010-07-01 Searete Llc Methods and systems for presenting an inhalation experience
US20100163038A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US8694330B2 (en) * 2008-12-30 2014-04-08 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US20100163024A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Methods and systems for presenting an inhalation experience
US20100169259A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US8725529B2 (en) 2008-12-30 2014-05-13 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US8706518B2 (en) * 2008-12-30 2014-04-22 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US20100163027A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100166613A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US20100228097A1 (en) * 2009-03-04 2010-09-09 Warsaw Orthopedic, Inc. Methods and compositions to diagnose pain
US20100234925A1 (en) * 2009-03-16 2010-09-16 PinPoint U.S.A., Inc. Treatment of microbiological pathogens in a toe nail with antimicrobial light
AP2909A (en) 2009-03-17 2014-05-31 Concert Pharmaceuticals Inc Pyrazinoisoquinoline Compounds
CA2755809C (fr) * 2009-03-18 2014-02-18 Incarda Therapeutics, Inc. Doses unitaires, aerosols, trousses, et methodes pour traiter des affections cardiaques par administration pulmonaire
WO2010107761A1 (fr) 2009-03-18 2010-09-23 Acelrx Pharmaceuticals, Inc. Dispositifs de stockage et de distribution améliorés pour l'administration de formes posologiques transmucosales orales
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
US20100300433A1 (en) * 2009-05-28 2010-12-02 Alexza Pharmaceuticals, Inc. Substrates for Enhancing Purity or Yield of Compounds Forming a Condensation Aerosol
US20120244122A1 (en) 2009-05-28 2012-09-27 Masse Craig E Peptides for the Treatment of HCV Infections
EP2690092B1 (fr) 2009-06-18 2016-03-16 Concert Pharmaceuticals Inc. Dérivés d'isoindoline-1,3-dione deutérés en tant qu'inhibiteurs de TNF-alpha et PDE4
WO2011005520A1 (fr) 2009-06-23 2011-01-13 Concert Pharmaceuticals, Inc. Dérivés de triazolo-pyridazine modifiés par deutérium comme modulateurs du récepteur gabaa
US20110171141A1 (en) * 2009-06-26 2011-07-14 Kellerman Donald J Administration of dihydroergotamine mesylate particles using a metered dose inhaler
US8617583B2 (en) * 2009-07-17 2013-12-31 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US8814922B2 (en) * 2009-07-22 2014-08-26 New Star Lasers, Inc. Method for treatment of fingernail and toenail microbial infections using infrared laser heating and low pressure
US8231891B2 (en) * 2009-07-31 2012-07-31 Warsaw Orthopedic, Inc. Implantable drug depot for weight control
US10758582B2 (en) * 2009-08-17 2020-09-01 Xten Capital Group, Inc. Vaporized medicants and methods of use
EP3336543A1 (fr) * 2009-09-09 2018-06-20 Sensa Bues AB Détection de drogues dans l'air expiré
CN102596264B (zh) 2009-10-13 2016-09-07 菲利普莫里斯生产公司 空气清新设备
US8278460B2 (en) 2009-10-15 2012-10-02 Concert Pharmaceuticals, Inc. Substituted benzimidazoles
US20110097375A1 (en) 2009-10-26 2011-04-28 Warsaw Orthopedic, Inc. Formulation for preventing or reducing bleeding at a surgical site
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
US20110100360A1 (en) * 2009-11-02 2011-05-05 Joseph Dee Faram Composite lung therapy device and method
US9151425B2 (en) * 2009-11-02 2015-10-06 Comedica Incorporated Multiple conduit connector apparatus and method
US8716478B2 (en) 2010-01-27 2014-05-06 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US20140018379A1 (en) 2010-02-18 2014-01-16 Concert Pharmaceuticals Inc. Pyrimidine derivatives
WO2011106703A2 (fr) 2010-02-26 2011-09-01 Anchor Therapeutics, Inc. Composés de récepteur cxcr4
EP3144296A1 (fr) 2010-03-02 2017-03-22 Concert Pharmaceuticals, Inc. Dérivés de tétrahydronaphtalène deutéré
US8575361B2 (en) 2010-03-02 2013-11-05 Concert Pharmaceuticals Inc. Tetrahydronaphthalene derivatives
WO2012009446A1 (fr) 2010-07-16 2012-01-19 Concert Pharmaceuticals Inc. Nouveaux dérivés pyrimidinecarboxamide
US20130142868A1 (en) * 2010-08-20 2013-06-06 University Of Washington Circumferential Aerosol Device for Delivering Drugs to Olfactory Epithelium and Brain
US20120048963A1 (en) 2010-08-26 2012-03-01 Alexza Pharmaceuticals, Inc. Heat Units Using a Solid Fuel Capable of Undergoing an Exothermic Metal Oxidation-Reduction Reaction Propagated without an Igniter
EA028743B1 (ru) 2010-09-07 2017-12-29 Анакор Фармасьютикалс, Инк. Производные бензоксаборолов в качестве антибактериальных средств
DE102010041840A1 (de) * 2010-10-01 2012-04-05 Bayerische Motoren Werke Aktiengesellschaft Verfahren zur Herstellung einer Ventilationsbohrung in einem Lagerstuhl eines Kurbelgehäuses einer Hubkolben-Brennkraftmaschine
WO2012079075A1 (fr) 2010-12-10 2012-06-14 Concert Pharmaceuticals, Inc. Dérivés de phtalimide deutérés
IL298116A (en) 2010-12-22 2023-01-01 Syqe Medical Ltd Method and system for drug delivery
US8447329B2 (en) 2011-02-08 2013-05-21 Longsand Limited Method for spatially-accurate location of a device using audio-visual information
AU2012223160B2 (en) 2011-03-03 2016-08-18 Impel Pharmaceuticals Inc. Nasal drug delivery device
WO2012129381A1 (fr) 2011-03-22 2012-09-27 Concert Pharmaceuticals Inc. Preladenant deutéré
WO2012151361A1 (fr) 2011-05-03 2012-11-08 Concert Pharmaceuticals Inc. Dérivés de carbamoylpyridone
JP6645735B2 (ja) 2011-05-09 2020-02-14 インペル ニューロファーマ インコーポレイテッド 鼻薬送達用ノズル
WO2012154738A1 (fr) 2011-05-09 2012-11-15 The Cleveland Clinic Foundation Composition et procédé pour améliorer la santé intestinale
US20140128469A1 (en) 2011-05-10 2014-05-08 Concert Pharmaceuticals Inc. Deuterated n-butyl bumetanide
AU2012255711B2 (en) 2011-05-18 2017-05-04 Vertex Pharmaceuticals (Europe) Limited Deuterated derivatives of ivacaftor
CN104254540A (zh) 2012-01-09 2014-12-31 安科治疗公司 Apj受体化合物
WO2013130849A1 (fr) 2012-02-29 2013-09-06 Concert Pharmaceuticals, Inc. Dérivés de phthalimide dioxopipéridinyle substitués
US20150066550A1 (en) * 2012-03-30 2015-03-05 Nec Corporation Flow line data analysis device, system, non-transitory computer readable medium and method
US9328113B2 (en) 2012-04-13 2016-05-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US9249093B2 (en) 2012-04-20 2016-02-02 Concert Pharmaceuticals, Inc. Deuterated rigosertib
EP2861600A1 (fr) 2012-06-15 2015-04-22 Concert Pharmaceuticals Inc. Dérivés deutérés de ruxolitinib
CA2908929C (fr) 2012-07-12 2021-01-26 Concert Pharmaceuticals, Inc. Idebenone deuteree
ES2717279T3 (es) 2012-08-17 2019-06-20 Concert Pharmaceuticals Inc Baricitinib deuterada
EP2711006A1 (fr) 2012-09-21 2014-03-26 Basil Rigas Produit comprenant un matériau contenant de la nicotine et un agent anticancéreux
MY183582A (en) 2012-11-19 2021-02-26 Vertex Pharmaceuticals Europe Ltd Deuterated cftr potentiators
US10034988B2 (en) 2012-11-28 2018-07-31 Fontem Holdings I B.V. Methods and devices for compound delivery
US12080401B2 (en) 2012-12-03 2024-09-03 Metrohealth Ventures Llc Combination respiratory therapy device, system and method
US9795752B2 (en) 2012-12-03 2017-10-24 Mhs Care-Innovation, Llc Combination respiratory therapy device, system, and method
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) * 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
CA2895846A1 (fr) 2012-12-20 2014-06-26 Concert Pharmaceuticals, Inc. Inhibiteurs alk deuteres
WO2014110322A2 (fr) 2013-01-11 2014-07-17 Concert Pharmaceuticals, Inc. Dérivés substitués de dioxopipéridinyl phtalimide
US9186860B2 (en) * 2013-01-28 2015-11-17 Carl D. Luenser Vaporizer kit for tobacco, medications, and the like
WO2014150043A1 (fr) 2013-03-15 2014-09-25 Concert Pharmaceuticals Inc. Inhibiteurs de l'enzyme udp-glucose : n-acyl-sphingosine glucosyltransférase
EP2970209B1 (fr) 2013-03-15 2018-12-26 CoNCERT Pharmaceuticals, Inc. Palbociclib deutéré avec une stabilité métabolique améliorée
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
HU231191B1 (hu) 2013-04-15 2021-08-30 Szegedi Tudományegyetem Izotóp tartalmú morfin molekulák
US10537692B2 (en) 2013-04-28 2020-01-21 Impel Neuropharma, Inc. Medical unit dose container
AU2013388034B2 (en) 2013-04-30 2019-08-15 Vectura Inc. Dry powder formulations and methods of use
US9549909B2 (en) 2013-05-03 2017-01-24 The Katholieke Universiteit Leuven Method for the treatment of dravet syndrome
CN104274426A (zh) 2013-07-03 2015-01-14 陆克塞纳医药公司 昂丹司琼细粉、昂丹司琼气溶胶组合物及其用途
CN104274427A (zh) * 2013-07-03 2015-01-14 陆克塞纳医药公司 格拉司琼气溶胶组合物及其用途
US9724341B2 (en) 2013-07-11 2017-08-08 Alexza Pharmaceuticals, Inc. Nicotine salt with meta-salicylic acid
WO2015010045A1 (fr) 2013-07-18 2015-01-22 Anchor Therapeutics, Inc. Composés de récepteurs apj
WO2015009889A1 (fr) 2013-07-18 2015-01-22 Concert Pharmaceuticals, Inc. Dérivés deutériés d'intédanib et leur utilisation pour le traitement de troubles prolifératifs
MX348595B (es) 2013-08-02 2017-06-21 Laboratorio Raam De Sahuayo S A De C V Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion.
US9676790B2 (en) 2013-08-30 2017-06-13 Concert Pharmaceuticals, Inc. Substituted thienotriazolodiazapines
WO2015042412A1 (fr) 2013-09-20 2015-03-26 E-Nicotine Technology. Inc. Dispositifs et procédés de modification de dispositifs de distribution
US9364815B2 (en) * 2013-11-07 2016-06-14 Saudi Basic Industries Corporation Method of preparing an alumina catalyst support and catalyst for dehydrogenation reactions, and its use
WO2015095644A1 (fr) 2013-12-20 2015-06-25 AntiOP, Inc. Compositions de naloxone intranasales et leurs procédés de préparation et d'utilisation
JP7009059B2 (ja) 2013-12-24 2022-02-10 ヴァージニア コモンウェルス ユニバーシティ 酸素化コレステロール硫酸塩(ocs)の使用
BR112016014760A2 (pt) 2013-12-24 2017-12-12 Harvard College composto, composição farmacêutica, métodos para tratamento de uma condição, para inibir e validar atividade de cinase, para modular o trajeto de b-catenina e o trajeto de tgfb/bmp em uma célula, para modular a atividade de stat1 e de hif-1-alfa em uma célula, para aumentar a expressão de bim e para preparar um composto, mutante, e, proteína
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
WO2015127315A1 (fr) 2014-02-20 2015-08-27 Otitopic Inc. Préparations de poudre sèche à inhaler
CN106414122A (zh) * 2014-03-10 2017-02-15 老虎工具国际公司 用于货车驾驶室的加热和冷却系统和方法
WO2015148649A2 (fr) * 2014-03-26 2015-10-01 Basil Rigas Systèmes et procédés d'amélioration des effets de produits du tabac
WO2015155544A1 (fr) * 2014-04-10 2015-10-15 Patrick Crowley Administration d'agents anti-inflammatoires non stéroïdiens par l'intermédiaire du tractus nasal pour traiter des troubles neurologiques
WO2015179772A1 (fr) 2014-05-23 2015-11-26 Concert Pharmaceuticals, Inc. Composés phénylquinazolinone et phénylisoquinolinone deutérés
CA2949559C (fr) 2014-06-06 2023-08-29 Research Triangle Institute Agonistes du recepteur de l'apeline (apj) et leurs utilisations
JP2015229527A (ja) * 2014-06-09 2015-12-21 三光機械株式会社 多列式自動包装機
US11298477B2 (en) 2014-06-30 2022-04-12 Syqe Medical Ltd. Methods, devices and systems for pulmonary delivery of active agents
IL294077A (en) 2014-06-30 2022-08-01 Syqe Medical Ltd Method and device for vaporizing and inhaling substances
EP3160558B1 (fr) 2014-06-30 2020-02-12 Syqe Medical Ltd. Dispositif inhalateur à régulation d'écoulement
CN113616883B (zh) 2014-06-30 2023-06-06 Syqe医药有限公司 向受试者肺部递送植物材料中的至少一药理活性剂的系统
WO2016001922A1 (fr) 2014-06-30 2016-01-07 Syqe Medical Ltd. Procédés, dispositifs et systèmes utilisables en vue de l'administration pulmonaire d'agents actifs
PL3539599T3 (pl) 2014-06-30 2022-02-21 Syqe Medical Ltd. Wkład z dawką leku dla urządzenia inhalatora
CA2962367A1 (fr) 2014-09-29 2016-04-07 Zogenix International Limited Systeme de commande destine a commander la distribution d'un medicament
WO2016061488A1 (fr) 2014-10-17 2016-04-21 Concert Pharmaceuticals, Inc. Inhibiteurs de réabsorption d'amines
WO2016073545A1 (fr) 2014-11-06 2016-05-12 Concert Pharmaceuticals, Inc. Acides benzoïques de phényloxadiazole
WO2016089814A1 (fr) 2014-12-02 2016-06-09 Concert Pharmaceuticals, Inc. Analogues deutériés du daclatasvir
NZ732808A (en) 2014-12-23 2021-12-24 Acelrx Pharmaceuticals Inc Systems, devices and methods for dispensing oral transmucosal dosage forms
WO2016105547A1 (fr) 2014-12-24 2016-06-30 Concert Pharmaceuticals, Inc. Dasabuvir deutéré
WO2016109795A1 (fr) 2014-12-31 2016-07-07 Concert Pharmaceuticals, Inc. Funapide et difluorofunapide deutérés
CN107405346A (zh) 2015-01-20 2017-11-28 Xoc制药股份有限公司 异麦角灵化合物及其用途
CN107428745A (zh) 2015-01-20 2017-12-01 Xoc制药股份有限公司 麦角灵化合物及其用途
US20160206610A1 (en) * 2015-01-20 2016-07-21 Xoc Pharmaceuticals, Inc. Methods for treating and/or preventing emesis and/or nausea including acute and/or delayed nausea and/or acute emesis and/or delayed emesis
WO2016144830A1 (fr) 2015-03-06 2016-09-15 Concert Pharmaceuticals, Inc. Emricasan deutéré
PL3268072T3 (pl) 2015-03-11 2024-07-01 Alexza Pharmaceuticals, Inc. Zastosowanie materiałów antystatycznych w drogach przepływu powietrza w procesie termicznej kondensacji aerozolu
CA2981495C (fr) 2015-03-31 2023-09-26 Vertex Pharmaceuticals (Europe) Limited Vx-661 deutere
CN111603643B (zh) 2015-04-02 2023-05-23 希尔-罗姆服务私人有限公司 呼吸装置的压力控制
WO2016176335A1 (fr) 2015-04-27 2016-11-03 Concert Pharmaceuticals, Inc. Otx-015 deutéré
EP3294298A4 (fr) 2015-05-08 2018-10-17 President and Fellows of Harvard College Analogues de la cortistatine, synthèses, et utilisations de ces derniers
WO2017003469A1 (fr) * 2015-06-30 2017-01-05 University Of South Florida Inhibiteurs de la protéine fkbp51 à partir d'un criblage de médicaments à rendement élevé et procédés d'utilisation
EP3316889A4 (fr) 2015-07-01 2018-11-14 President and Fellows of Harvard College Analogues de la cortistatine, et synthèses et leurs utilisations
AU2016287582B2 (en) 2015-07-02 2020-03-12 Civitas Therapeutics, Inc. Triptan powders for pulmonary delivery
WO2017020005A1 (fr) 2015-07-30 2017-02-02 Concert Pharmaceuticals, Inc. Composés de morphinane utilisés pour le traitement de l'agitation
US20180243289A1 (en) 2015-07-30 2018-08-30 Concert Pharmaceuticals, Inc. Deuterated morphinan compounds for treating agitation
EP3341059B1 (fr) 2015-09-10 2022-03-02 Impel NeuroPharma Inc. Dispositif d'administration nasale en ligne
EP3377179B1 (fr) 2015-11-19 2021-04-07 Concert Pharmaceuticals Inc. Epi-743 deutéré
KR20180090852A (ko) 2015-12-09 2018-08-13 리써치 트라이앵글 인스티튜트 개선된 아펠린 수용체(apj) 효능제 및 이의 용도
EP3393470B1 (fr) 2015-12-22 2021-01-20 Zogenix International Limited Analogues de fenfluramine résistant au métabolisme et procédés pour les utiliser
CN113499330A (zh) * 2015-12-22 2021-10-15 周格尼克斯国际有限公司 芬氟拉明组合物及其制备方法
US10092036B2 (en) * 2015-12-28 2018-10-09 Rai Strategic Holdings, Inc. Aerosol delivery device including a housing and a coupler
ES2874087T3 (es) 2016-01-06 2021-11-04 Syqe Medical Ltd Tratamiento terapéutico con dosis bajas
SG11201805788WA (en) 2016-02-01 2018-08-30 Incarda Therapeutics Inc Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation
US20170216220A1 (en) * 2016-02-03 2017-08-03 Intelgenx Corp. Loxapine film oral dosage form
WO2017147003A1 (fr) 2016-02-26 2017-08-31 Novobiotic Pharmaceuticals, Llc Nouveaux antibiotiques macrocycliques et leurs utilisations
WO2017218796A1 (fr) 2016-06-15 2017-12-21 Ott Harald C Marquage métabolique et amélioration moléculaire de matériels biologiques à l'aide de réactions bioorthogonales
PT3478664T (pt) 2016-07-04 2020-12-28 Avanir Pharmaceuticals Inc Métodos para a síntese de dextrometorfano deuterado
CN109789103A (zh) 2016-08-01 2019-05-21 布里格姆妇女医院 用于递送蛋白质和肽的颗粒
IL290727B2 (en) 2016-08-24 2023-12-01 Zogenix International Ltd A formulation for inhibiting the formation of 5–HT 2B agonists and methods of using it
DE102016221705B4 (de) 2016-11-07 2018-05-17 Schaeffler Technologies AG & Co. KG Zahnrad aus einem Zahnradverbund und Verfahren zur Herstellung eines Zahnradverbundes
US20180185347A1 (en) * 2016-11-16 2018-07-05 Transition Therapeutics (Ireland 2) Limited Tetrahydrocyclopenta[b]indole compounds and phosphodiesterase inhibitors for the treatment of the signs and symptoms of bhp
US11241383B2 (en) 2016-12-09 2022-02-08 Alexza Pharmaceuticals, Inc. Method of treating epilepsy
JP7071342B6 (ja) 2016-12-21 2023-12-20 リサーチ トライアングル インスティテュート 改善されたバイオアベイラビリティを有するジアリールプリン誘導体
LT3474850T (lt) 2017-02-02 2020-08-10 Otolanum Ag Intranazalinė kompozicija, apimanti betahistiną
AU2018231832A1 (en) 2017-03-10 2019-08-08 Quiapeg Pharmaceuticals Ab Releasable conjugates
EP3595653B1 (fr) 2017-03-13 2023-03-08 Beyondspring Pharmaceuticals, Inc. Compositions de plinabuline et leur utilisation
US10441537B2 (en) 2017-05-10 2019-10-15 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
JP7228574B2 (ja) 2017-05-19 2023-02-24 スパーブ ウィズダム リミテッド レシキモドの誘導体
BR112019025420A2 (pt) 2017-06-01 2020-06-16 Xoc Pharmaceuticals, Inc. Compostos policíclicos e usos destes
EP3638690A4 (fr) 2017-06-15 2020-07-01 Mayo Foundation for Medical Education and Research Méthodes de traitement de gliomes à l'aide d'un inhibiteur de stat3
EP3641756B1 (fr) 2017-06-16 2023-08-09 The General Hospital Corporation Composés tricycliques utilisés comme inhibiteurs du cyp1
US9993486B1 (en) 2017-06-19 2018-06-12 Tlc Therapeutics, Llc Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability
CN109391578B (zh) * 2017-08-11 2022-07-22 华为技术有限公司 信号发送方法、信号接收方法、终端设备及网络设备
US10682317B2 (en) 2017-09-26 2020-06-16 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation
AU2018352382B2 (en) 2017-10-16 2022-06-02 Dana-Farber Cancer Institute, Inc. Compounds and methods for treating cancer
US11571532B2 (en) 2017-11-21 2023-02-07 Impel Pharmaceuticals Inc. Intranasal device with dip tube
CA3081680A1 (fr) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Dispositif intra-nasale avec interface d'entree
RU2020125871A (ru) 2018-01-05 2022-02-07 Импел Ньюрофарма, Инк. Интраназальная доставка дигидроэрготамина с помощью прецизионного устройства для доставки в обонятельную область
AU2019205329B2 (en) 2018-01-05 2023-04-20 Impel Pharmaceuticals Inc. Intranasal delivery of olanzapine by precision olfactory device
KR20200115547A (ko) 2018-01-31 2020-10-07 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 섬유성 병리를 치료하는 방법
WO2019183470A2 (fr) 2018-03-22 2019-09-26 Incarda Therapeutics, Inc. Nouvelle méthode pour ralentir le rythme ventriculaire
EP3790537A1 (fr) 2018-05-11 2021-03-17 Zogenix International Limited Compositions et méthodes pour traiter la mort subite provoquée par la crise épileptique
WO2020009560A1 (fr) 2018-07-04 2020-01-09 AMÉZCUA AMÉZCUA, Federico Combinaison pharmaceutique synergique de l'énantiomère actif s-kétorolac et de gabapentine pour le traitement de la douleur neuropathique
EP3817736A4 (fr) 2018-07-05 2021-07-28 Mayo Foundation for Medical Education and Research Inhibiteurs de pikfyve
JP2021532098A (ja) 2018-07-19 2021-11-25 インペル ニューロファーマ インコーポレイテッド パーキンソン病の治療のためのレボドパおよびドーパデカルボキシラーゼ阻害剤の呼吸管路送達
CA3108680A1 (fr) 2018-08-13 2020-02-20 AMEZCUA AMEZCUA, Federico Composition pharmaceutique synergique d'aceclofenac et de betamethasone pour le traitement de la douleur dans les formes localisees d'affections rhumatismales
US11090449B2 (en) 2018-08-21 2021-08-17 Vivera Pharmaceuticals Inc. Smart inhaler device with automated dose delivery, measurement, and management
US11083850B2 (en) 2018-08-21 2021-08-10 Vivera Pharmaceuticals Inc. Secure smart dosing system with automated delivery, measurement, and management
KR20210057130A (ko) 2018-09-12 2021-05-20 퀴아펙 파마슈티칼스 에이비 방출가능한 glp-1 컨쥬게이트
BR112021012950A2 (pt) 2019-01-03 2021-09-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Métodos e materiais para aumentar os níveis de polipeptídeo do fator de transcrição eb
CN113473967B (zh) 2019-01-03 2022-09-09 英倍尔制药公司 经鼻药物递送装置
MX2019000312A (es) 2019-01-08 2019-10-09 Federico Amezcua Amezcua Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico.
CN109674773A (zh) * 2019-02-22 2019-04-26 南京中医药大学 一种肺部给药的昔多芬药物微粒及其制备方法与应用
WO2020236658A1 (fr) 2019-05-17 2020-11-26 Impel Neuropharma, Inc. Dispositif d'administration nasale à usage unique
WO2021021922A1 (fr) 2019-07-30 2021-02-04 Mayo Foundation For Medical Education And Research Composés et méthodes de traitement de pathologies fibrotiques
US11007185B2 (en) 2019-08-01 2021-05-18 Incarda Therapeutics, Inc. Antiarrhythmic formulation
US11364225B2 (en) 2019-08-21 2022-06-21 Bn Intellectual Properties, Inc. Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same
EP4030941A1 (fr) 2019-09-16 2022-07-27 Vapor Cartridge Technology LLC Système d'administration de médicament avec substrats empilables
US12070554B2 (en) 2019-11-11 2024-08-27 Hill-Rom Services Pte. Ltd. Pneumatic connector apparatus and method
WO2021163252A1 (fr) * 2020-02-14 2021-08-19 Teikoku Pharma Usa, Inc. Compositions topiques de naloxone et leurs procédés d'utilisation
EP3868364A1 (fr) 2020-02-24 2021-08-25 GH Research Limited Aérosol comrpenant 5-methoxy-n,n-dimethyltryptamine
US11612574B2 (en) 2020-07-17 2023-03-28 Zogenix International Limited Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
US11071739B1 (en) 2020-09-29 2021-07-27 Genus Lifesciences Inc. Oral liquid compositions including chlorpromazine
US20220117916A1 (en) * 2020-10-19 2022-04-21 SafeRx Pharmaceuticals, LLC Combination Products to Mitigate the Risk of Non-Benzodiazepine Benzodiazepine Agonist Adverse Reaction and Overdose
EP4159192A1 (fr) 2021-09-30 2023-04-05 Biomind Labs Inc Spray nasal à base de diméthyltriptamine pour le traitement personnalisé des troubles neurologiques et psychiatriques
TW202325285A (zh) * 2021-10-14 2023-07-01 靜岡縣公立大學法人 粉末製劑
IT202100031637A1 (it) 2021-12-17 2023-06-17 Universita’ Degli Studi Di Parma Polveri per inalazione e procedimento di produzione
EP4349175A1 (fr) 2022-10-05 2024-04-10 The Procter & Gamble Company Composition antimicrobienne comprenant un alkylglycoside modifié et un acide organique

Family Cites Families (273)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US58009A (en) * 1866-09-11 Improved condenser
US32638A (en) * 1861-06-25 Boot-heel
US113557A (en) * 1871-04-11 Improvement in metal screws and nuts
US30285A (en) * 1860-10-09 Fruit-drier
GB502761A (en) 1938-01-29 1939-03-24 Christopher Engelbreth Improvements in and relating to hand inhalation apparatus
US2902484A (en) 1954-04-27 1959-09-01 Rhone Poulenc Sa Phenthiazine derivatives and processes for their preparation
US3474101A (en) 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
BE623427A (fr) 1961-10-10
GB972363A (en) 1962-08-18 1964-10-14 Rambold Adolf Wrapper band for teabag or the like
US3169095A (en) 1962-10-30 1965-02-09 Rexall Drug Chemical Self-propelling powder-dispensing compositions
NL289785A (fr) 1962-11-29
GB1063512A (en) 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3456247A (en) * 1966-01-14 1969-07-15 Ibm Coupled film storage device
IL26896A (en) 1966-01-19 1970-11-30 Endo Lab 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
US3987052A (en) 1969-03-17 1976-10-19 The Upjohn Company 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
USRE30285E (en) 1972-05-22 1980-05-27 Spraying devices, in particular nebulizing devices
US3949743A (en) 1973-03-19 1976-04-13 Schick Incorporated Medicated vapor production method and apparatus
US3982095A (en) 1973-10-04 1976-09-21 Searle Cardio-Pulmonary Systems Inc. Respiratory humidifier
US3894040A (en) 1974-09-16 1975-07-08 American Home Prod 2,5,6,7-Tetrahydro-3H-imidazo(1,2-D)(1,4)benzodiazepine-5,6-dicarboxylic acid esters
US4121583A (en) 1976-07-13 1978-10-24 Wen Yuan Chen Method and apparatus for alleviating asthma attacks
US4141369A (en) 1977-01-24 1979-02-27 Burruss Robert P Noncombustion system for the utilization of tobacco and other smoking materials
SE7812207L (sv) 1977-12-01 1979-06-02 Welsh Nat School Med Apparat, forfarande och framstellda produkter for anvendning vid administration av antihistaminer
US4183912A (en) 1978-01-16 1980-01-15 American Home Products Corporation Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine
US4484451A (en) * 1978-09-05 1984-11-27 United Air Specialists, Inc. Two-stage gas condenser with feedback cooling
IL59407A (en) 1979-03-06 1983-12-30 Sanofi Sa Di-n-propylacetic acid diesters of glycerol,their preparation and pharmaceutical compositions containing them
US4654370A (en) 1979-03-12 1987-03-31 Abbott Laboratories Glyceryl valproates
US4229447A (en) 1979-06-04 1980-10-21 American Home Products Corporation Intraoral methods of using benzodiazepines
EP0039369B1 (fr) 1980-05-02 1983-06-15 Schering Corporation Solvats d'esters de béclométhasone, procédé pour leur préparation et préparation d'une formulation
US4303083A (en) 1980-10-10 1981-12-01 Burruss Jr Robert P Device for evaporation and inhalation of volatile compounds and medications
US4376767A (en) 1981-01-02 1983-03-15 Merck & Co., Inc. Pyridylmethyl esters of selected bio-affecting carboxylic acids
DE3116951C2 (de) 1981-04-29 1984-12-20 Drägerwerk AG, 2400 Lübeck Vorrichtung zur Beimischung flüssiger Narkosemittel in das dem Patienten zuzuführende Atemgas
DE3224849A1 (de) 1982-07-02 1984-01-05 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Dampfinhaliergeraet
US4508726A (en) 1982-09-16 1985-04-02 The Upjohn Company Treatment of panic disorders with alprazolam
EP0120968B1 (fr) 1982-09-30 1988-06-29 Dainihon Jochugiku Co., Ltd. Appareil de volatilisation thermique d'un agent medicinal
US4474191A (en) 1982-09-30 1984-10-02 Steiner Pierre G Tar-free smoking devices
US4753758A (en) 1983-05-19 1988-06-28 Intertech Resources Inc. Respiratory humidifier
DE3326089A1 (de) 1983-07-20 1985-02-07 Gödecke AG, 1000 Berlin Zur inhalation bestimmte darreichungsform von calcium-antagonisten
AU591451B2 (en) 1983-08-01 1989-12-07 Mclean Hospital Corporation, The Gamma amino butyric acid esters
US4588721A (en) 1983-09-12 1986-05-13 The Upjohn Company Treatment of negative symptoms of schizophrenia
US4566552A (en) * 1983-11-16 1986-01-28 International Harvester Company Hood tilt retardation system
US4683231A (en) 1984-03-02 1987-07-28 Research Foundation For Mental Hygiene, Inc. Method of preventing withdrawal symptoms associated with the cessation or reduction of tobacco smoking
US4793365A (en) 1984-09-14 1988-12-27 R. J. Reynolds Tobacco Company Smoking article
US4854331A (en) 1984-09-14 1989-08-08 R. J. Reynolds Tobacco Company Smoking article
US5042509A (en) 1984-09-14 1991-08-27 R. J. Reynolds Tobacco Company Method for making aerosol generating cartridge
US5067499A (en) 1984-09-14 1991-11-26 R. J. Reynolds Tobacco Company Smoking article
US5020548A (en) 1985-08-26 1991-06-04 R. J. Reynolds Tobacco Company Smoking article with improved fuel element
CN1018607B (zh) 1984-12-21 1992-10-14 美国耳·杰·瑞诺兹烟草公司 吸烟制品
US4928714A (en) 1985-04-15 1990-05-29 R. J. Reynolds Tobacco Company Smoking article with embedded substrate
JPS63500175A (ja) 1985-05-22 1988-01-21 リポソ−ム テクノロジ−,インコ−ポレイテツド リポソ−ム吸入法および吸入システム
US4989619A (en) 1985-08-26 1991-02-05 R. J. Reynolds Tobacco Company Smoking article with improved fuel element
US4756318A (en) 1985-10-28 1988-07-12 R. J. Reynolds Tobacco Company Smoking article with tobacco jacket
US5060666A (en) 1985-10-28 1991-10-29 R. J. Reynolds Tobacco Company Smoking article with tobacco jacket
US5033483A (en) 1985-10-28 1991-07-23 R. J. Reynolds Tobacco Company Smoking article with tobacco jacket
JPS62204756A (ja) * 1986-03-04 1987-09-09 大研医工株式会社 薬剤揮散方法および装置
JP2573275B2 (ja) 1986-03-10 1997-01-22 ブルグハルト,クルト 薬学的製剤及びその製造法
US4708151A (en) 1986-03-14 1987-11-24 R. J. Reynolds Tobacco Company Pipe with replaceable cartridge
US4771795A (en) 1986-05-15 1988-09-20 R. J. Reynolds Tobacco Company Smoking article with dual burn rate fuel element
US4917120A (en) 1986-05-21 1990-04-17 Advanced Tobacco Products, Inc. Nicotine impact modification
US4735217A (en) * 1986-08-21 1988-04-05 The Procter & Gamble Company Dosing device to provide vaporized medicament to the lungs as a fine aerosol
US4858630A (en) 1986-12-08 1989-08-22 R. J. Reynolds Tobacco Company Smoking article with improved aerosol forming substrate
US4734560A (en) 1987-01-20 1988-03-29 Medical Enterprises, Ltd. Vaporizing unit
US4819665A (en) 1987-01-23 1989-04-11 R. J. Reynolds Tobacco Company Aerosol delivery article
US4924883A (en) 1987-03-06 1990-05-15 R. J. Reynolds Tobacco Company Smoking article
US5017575A (en) 1987-06-09 1991-05-21 Golwyn Daniel H Treatment of immunologically based disorders, specifically Crohn's disease
GB8713645D0 (en) 1987-06-11 1987-07-15 Imp Tobacco Ltd Smoking device
US5019122A (en) 1987-08-21 1991-05-28 R. J. Reynolds Tobacco Company Smoking article with an enclosed heat conductive capsule containing an aerosol forming substance
US4906417A (en) 1988-02-08 1990-03-06 Associated Mills Inc. Humidifier
US4853517A (en) 1988-03-28 1989-08-01 John G. Bowen Vaporizing unit
US4906119A (en) * 1988-04-14 1990-03-06 Lloyd Hartford Handwriting stabilizer
DE3815221C2 (de) 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US4881556A (en) 1988-06-06 1989-11-21 R. J. Reynolds Tobacco Company Low CO smoking article
US5345951A (en) 1988-07-22 1994-09-13 Philip Morris Incorporated Smoking article
US4947874A (en) 1988-09-08 1990-08-14 R. J. Reynolds Tobacco Company Smoking articles utilizing electrical energy
US4947875A (en) 1988-09-08 1990-08-14 R. J. Reynolds Tobacco Company Flavor delivery articles utilizing electrical energy
US4922901A (en) 1988-09-08 1990-05-08 R. J. Reynolds Tobacco Company Drug delivery articles utilizing electrical energy
EP0358114A3 (fr) 1988-09-08 1990-11-14 R.J. Reynolds Tobacco Company Appareil électrique pour administrer des aérosols
US4950664A (en) 1988-09-16 1990-08-21 Rugby-Darby Group Companies, Inc. Nasal administration of benzodiazepine hypnotics
USRE36744E (en) 1988-09-16 2000-06-20 Ribogene, Inc. Nasal administration of benzodiazepine hypnotics
US4963289A (en) 1988-09-19 1990-10-16 The United States Of America As Represented By The United States Department Of Energy Method for producing monodisperse aerosols
US5511726A (en) 1988-09-23 1996-04-30 Battelle Memorial Institute Nebulizer device
US4917119A (en) 1988-11-30 1990-04-17 R. J. Reynolds Tobacco Company Drug delivery article
US4906476A (en) 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
GB8900267D0 (en) 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
DE3908161A1 (de) 1989-03-13 1990-09-27 Bat Cigarettenfab Gmbh Rauchbarer artikel
JP3062760B2 (ja) * 1989-03-14 2000-07-12 コニカ株式会社 複合レンズ
JPH05501505A (ja) 1989-04-28 1993-03-25 ライカー ラボラトリーズ,インコーポレイティド 乾燥粉末吸入装置
CA2054197A1 (fr) 1989-05-05 1990-11-06 Christopher O'neill Augmentation de la fertilite
ES2046368T3 (es) * 1989-05-17 1994-02-01 Leifeld Gmbh & Co. Procedimiento para la fabricacion de una polea.
US4941483A (en) 1989-09-18 1990-07-17 R. J. Reynolds Tobacco Company Aerosol delivery article
US6313176B1 (en) 1989-10-17 2001-11-06 Everett J. Ellinwood, Jr. Dosing method of administering deprenyl via intraoral administration or inhalation administration
US6048857A (en) 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
US5707644A (en) 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
US5224498A (en) 1989-12-01 1993-07-06 Philip Morris Incorporated Electrically-powered heating element
US5144962A (en) 1989-12-01 1992-09-08 Philip Morris Incorporated Flavor-delivery article
US5060671A (en) * 1989-12-01 1991-10-29 Philip Morris Incorporated Flavor generating article
WO1991007947A1 (fr) 1989-12-05 1991-06-13 Ramsey Foundation Agents neurologiques administres par voie nasale au cerveau
GB2239807A (en) 1990-01-09 1991-07-17 Boc Group Plc Anaesthetic vaporiser
US5376386A (en) 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
US5099861A (en) 1990-02-27 1992-03-31 R. J. Reynolds Tobacco Company Aerosol delivery article
US5366770A (en) 1990-04-17 1994-11-22 Xingwu Wang Aerosol-plasma deposition of films for electronic cells
US5455043A (en) 1990-06-13 1995-10-03 Fischel-Ghodsian; Fariba Device for controlled release of vaporous medications through nasal route
US5126123A (en) 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations
ES2073685T5 (es) 1990-08-02 2002-03-01 Datex Ohmeda Inc Vaporizador de anestesico.
US5292499A (en) 1990-09-11 1994-03-08 University Of Wales College Of Cardiff Method of preparing medical aerosol formulations including drug dissolved in reverse micelles
US5166202A (en) 1990-09-19 1992-11-24 Trustees Of The University Of Pennsylvania Method for the treatment of panic disorder
US5175152A (en) 1990-09-28 1992-12-29 Singh Nikhilesh N Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
US5343226A (en) * 1990-09-28 1994-08-30 Dataproducts Corporation Ink jet ink supply apparatus
DE69229070T2 (de) 1991-02-09 1999-11-18 B.S.D. Bio Science Development Snc Di Omini C. & Zuccari G., Bussero Antireaktive antiasthmatische Wirkung von Acetylsalicylsäure durch Inhalation
US5993805A (en) 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
US5457100A (en) 1991-12-02 1995-10-10 Daniel; David G. Method for treatment of recurrent paroxysmal neuropsychiatric
US5639441A (en) 1992-03-06 1997-06-17 Board Of Regents Of University Of Colorado Methods for fine particle formation
US5626871A (en) 1992-06-12 1997-05-06 Teijin Limited Preparation for intratracheobronchial administration
US5622944A (en) 1992-06-12 1997-04-22 Affymax Technologies N.V. Testosterone prodrugs for improved drug delivery
US5607691A (en) 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
US5284133A (en) * 1992-07-23 1994-02-08 Armstrong Pharmaceuticals, Inc. Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means
AU5358694A (en) * 1992-10-28 1994-05-24 Charles A. Rosen Method and devices for delivering drugs by inhalation
US5672581A (en) 1993-01-29 1997-09-30 Aradigm Corporation Method of administration of insulin
US5724957A (en) 1993-01-29 1998-03-10 Aradigm Corporation Intrapulmonary delivery of narcotics
US5507277A (en) 1993-01-29 1996-04-16 Aradigm Corporation Lockout device for controlled release of drug from patient-activateddispenser
US5915378A (en) 1993-01-29 1999-06-29 Aradigm Corporation Creating an aerosolized formulation of insulin
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US5694919A (en) 1993-01-29 1997-12-09 Aradigm Corporation Lockout device for controlled release of drug from patient-activated dispenser
US5357257A (en) * 1993-04-05 1994-10-18 General Electric Company Apparatus and method for equalizing channels in a multi-channel communication system
US5497763A (en) 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
US5666977A (en) 1993-06-10 1997-09-16 Philip Morris Incorporated Electrical smoking article using liquid tobacco flavor medium delivery system
EP0706352B1 (fr) 1993-06-29 2002-03-20 Ponwell Enterprises Limited Distributeur
US5388574A (en) 1993-07-29 1995-02-14 Ingebrethsen; Bradley J. Aerosol delivery article
DE4328243C1 (de) 1993-08-19 1995-03-09 Sven Mielordt Rauch- oder Inhalationsvorrichtung
US5456247A (en) 1993-08-26 1995-10-10 Iowa State University Research Foundation, Inc. Method for delivering drugs soluble in a vaporization vehicle
FI98270C (fi) 1993-11-29 1997-05-26 Instrumentarium Oy Menetelmä ja sovitelma anesteetin höyrystämisen yhteydessä
US5543434A (en) 1994-02-25 1996-08-06 Weg; Stuart L. Nasal administration of ketamine to manage pain
US5451408A (en) 1994-03-23 1995-09-19 Liposome Pain Management, Ltd. Pain management with liposome-encapsulated analgesic drugs
US6102036A (en) 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
JP3911290B2 (ja) 1994-05-13 2007-05-09 アラダイム コーポレーション エアゾールを含む麻酔用処方
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US6413930B1 (en) 1994-10-14 2002-07-02 Glaxo Wellcome Spa Use of cck-b receptor antagonists for the treatment of sleep disorders
EP1486226A3 (fr) 1994-10-28 2005-11-09 Aradigm Corporation Appareil et procédé de création d'un brouillard d'aérosol d'un médicament respiratoire
US5767117A (en) 1994-11-18 1998-06-16 The General Hospital Corporation Method for treating vascular headaches
WO1996030068A1 (fr) 1995-03-31 1996-10-03 Aradigm Corporation Administration intrapulmonaire d'un medicament hematopoietique
US5758637A (en) 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US5612053A (en) 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
US6258341B1 (en) 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
DE19519056A1 (de) 1995-05-24 1997-01-16 Klinge Co Chem Pharm Fab Verwendung von Antidepressiva zur Behandlung von Asthma und/oder Atemwegserkrankungen mittels inhalatorischer Applikation
US5874481A (en) 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
US6245347B1 (en) 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
JPH0943487A (ja) 1995-08-01 1997-02-14 Fuji Photo Film Co Ltd ズームレンズ
US5649554A (en) 1995-10-16 1997-07-22 Philip Morris Incorporated Electrical lighter with a rotatable tobacco supply
AU7669496A (en) 1995-11-03 1997-05-22 University Of Kentucky Method for the intranasal administration of l-dopa prodrugs
US6017963A (en) 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
US5564442A (en) 1995-11-22 1996-10-15 Angus Collingwood MacDonald Battery powered nicotine vaporizer
US6041777A (en) * 1995-12-01 2000-03-28 Alliance Pharmaceutical Corp. Methods and apparatus for closed-circuit ventilation therapy
KR100450861B1 (ko) 1995-12-14 2005-03-16 다이쇼 세이야꾸 가부시끼가이샤 에어로졸제제
SE9504580L (sv) 1995-12-21 1997-06-22 Siemens Elema Ab Förfarande vid förgasning av en narkosvätska och en förgasare
WO1997027804A1 (fr) 1996-02-05 1997-08-07 Aradigm Corporation Imagerie de ventilation au moyen d'un generateur d'aerosol a fines particules
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US5927124A (en) * 1996-03-05 1999-07-27 Adaptive Motion Control Systems, Inc. Apparatus for bending and cutting tubing, and method of using same
GB9606188D0 (en) * 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
GB9606677D0 (en) 1996-03-29 1996-06-05 Glaxo Wellcome Inc Process and device
EP0896525B1 (fr) * 1996-04-29 2003-08-27 Dura Pharmaceuticals, Inc. Methode d'inhalation de poudre seche
US5743251A (en) 1996-05-15 1998-04-28 Philip Morris Incorporated Aerosol and a method and apparatus for generating an aerosol
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
GB9613015D0 (en) 1996-06-21 1996-08-28 Reckitt & Colman Inc Device
AU712546B2 (en) 1996-07-11 1999-11-11 Farmarc Nederland Bv Inclusion complex containing indole selective serotonin agonist
US5906202A (en) 1996-11-21 1999-05-25 Aradigm Corporation Device and method for directing aerosolized mist to a specific area of the respiratory tract
US6694975B2 (en) * 1996-11-21 2004-02-24 Aradigm Corporation Temperature controlling device for aerosol drug delivery
US6131570A (en) 1998-06-30 2000-10-17 Aradigm Corporation Temperature controlling device for aerosol drug delivery
EP0954282B1 (fr) 1997-01-16 2005-01-19 Massachusetts Institute Of Technology Preparation de particules pour inhalation
AU718967B2 (en) 1997-02-05 2000-05-04 Jagotec Ag Medical aerosol formulations
US5829435A (en) 1997-02-24 1998-11-03 Aradigm Corporation Prefilter for prevention of clogging of a nozzle in the generation of an aerosol and prevention of administration of undesirable particles
US5837713A (en) 1997-02-26 1998-11-17 Mayo Foundation For Medical Education And Research Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids
KR100289448B1 (ko) 1997-07-23 2001-05-02 미즈노 마사루 향미발생장치
US5874841A (en) * 1997-07-28 1999-02-23 Philips Electronics North America Corporation Sample-and-hold circuit for a switched-mode power supply
US6090212A (en) 1997-08-15 2000-07-18 Micro C Technologies, Inc. Substrate platform for a semiconductor substrate during rapid high temperature processing and method of supporting a substrate
JP2003525842A (ja) 1997-09-29 2003-09-02 インヘール セラピューティック システムズ, インコーポレイテッド 計量吸入器における使用のための安定化調製物
US6403597B1 (en) * 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US5915841A (en) * 1998-01-05 1999-06-29 Capstone Turbine Corporation Compliant foil fluid film radial bearing
US20020006181A1 (en) 1998-01-23 2002-01-17 Mackenzie Innes K. Method and device for estimating bone mineral content of the calcaneus
US6158431A (en) 1998-02-13 2000-12-12 Tsi Incorporated Portable systems and methods for delivery of therapeutic material to the pulmonary system
CN1138536C (zh) 1998-03-05 2004-02-18 日本新药株式会社 油/水型脂肪乳或其冻干组合物的应用
EP2338482A3 (fr) 1998-04-14 2011-12-21 The General Hospital Corporation Procédés de traitement des troubles neuropsychiatriques
AU4680699A (en) 1998-06-12 1999-12-30 Aradigm Corporation Methods of delivering aerosolized polynucleotides to the respiratory tract
US6095153A (en) 1998-06-19 2000-08-01 Kessler; Stephen B. Vaporization of volatile materials
TWI223598B (en) 1998-06-22 2004-11-11 Pfizer Ireland Pharmaceuticals An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
WO2000000215A1 (fr) 1998-06-29 2000-01-06 Inhale Therapeutic Systems, Inc. Systemes administration de particules et procedes d'utilisation
GB9814172D0 (en) 1998-06-30 1998-08-26 Andaris Ltd Formulation for inhalation
MA25590A1 (fr) * 1998-09-14 2002-12-31 Inhale Therapeutic Syst Agent actif de delivraison de poudre seche
US6234167B1 (en) * 1998-10-14 2001-05-22 Chrysalis Technologies, Incorporated Aerosol generator and methods of making and using an aerosol generator
US6509005B1 (en) 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
US6255334B1 (en) * 1998-10-30 2001-07-03 Pfizer Inc 5HT 1 receptor agonists and metoclopramide for the treatment of migraine
ATE353630T1 (de) 1998-11-12 2007-03-15 Transave Inc Inhalationssystem
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
ATE382386T1 (de) 1998-11-13 2008-01-15 Jagotec Ag Multidosis-trockenpulverinhalator mit pulverreservoir
US6070575A (en) 1998-11-16 2000-06-06 Aradigm Corporation Aerosol-forming porous membrane with certain pore structure
EP1137398B1 (fr) * 1998-12-11 2003-10-08 Pharmachemie B.V. Preparation pharmaceutique pour inhalation d'un opioide
US6376550B1 (en) 1999-02-09 2002-04-23 Asta Medica Ag Pharmaceutical compositions containing tramadol for migraine
WO2000047203A1 (fr) 1999-02-12 2000-08-17 Mqs, Inc. Formulation et systeme pour administration intra-orale de principes actifs
US6591839B2 (en) * 1999-02-17 2003-07-15 Dieter Meyer Filter material for reducing harmful substances in tobacco smoke
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
AU4450700A (en) 1999-04-27 2000-11-10 Eli Lilly And Company Insulin crystals for pulmonary administration
ES2226843T3 (es) 1999-05-03 2005-04-01 Battelle Memorial Institute Composiciones para dispersion por aerosol e inhalacion.
US6428769B1 (en) 1999-05-04 2002-08-06 Aradigm Corporation Acute testosterone administration
GB9912356D0 (en) * 1999-05-26 1999-07-28 Btg Int Ltd Generation of microfoam
NZ516083A (en) 1999-05-27 2003-08-29 Acusphere Inc Porous drug matrices and methods of manufacture thereof
EP1192009B1 (fr) 1999-06-11 2013-05-01 Aradigm Corporation Procede de production d'un aerosol
US20020061281A1 (en) 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
CA2378913C (fr) 1999-07-16 2010-02-23 Aradigm Corporation Systeme permettant d'arreter de fumer
US6358944B1 (en) * 1999-08-13 2002-03-19 Vela Pharmaceuticals, Inc. Methods and compositions for treating generalized anxiety disorder
MXPA02001857A (es) 1999-08-24 2003-07-14 Cellgate Inc Composiciones y metodos para incrementar la entrega de drogas a traves y dentro de tejidos epiteliales.
WO2001017568A2 (fr) 1999-09-07 2001-03-15 Conjuchem, Inc. Diffusion pulmonaire permettant la bioconjugaison
CA2379640C (fr) 1999-09-30 2006-11-28 Neurogen Corporation Heterocycles a substitution alkylene-diamine
JP3492349B2 (ja) * 1999-10-19 2004-02-03 ニチユソリューション株式会社 繁殖用雌ブタの飼育方法及び繁殖用雌ブタ用飼料
DK1666028T3 (da) 1999-10-29 2010-06-21 Novartis Ag Tørre pulversammensætninger med forbedret dispersitet
WO2001041732A1 (fr) 1999-12-06 2001-06-14 Gore Stanley L Compositions et procedes d'administration intranasale d'agents actifs destines au cerveau
US6853310B2 (en) * 1999-12-29 2005-02-08 Ge Medical Systems Information Technologies, Inc. Tri-mode medical telemetry antenna system
CA2401288A1 (fr) * 2000-02-28 2001-09-07 Vectura Limited Ameliorations apportees a l'administration de medicaments par voie orale
CZ20023637A3 (cs) * 2000-04-07 2003-02-12 Tap Pharmaceutical Products, Inc. Deriváty apomorfinu a způsoby jejich použití
US6632047B2 (en) 2000-04-14 2003-10-14 Board Of Regents, The University Of Texas System Heater element for use in an in situ thermal desorption soil remediation system
MY136453A (en) * 2000-04-27 2008-10-31 Philip Morris Usa Inc "improved method and apparatus for generating an aerosol"
EP1292314A2 (fr) 2000-05-23 2003-03-19 The Trustees of Columbia University in the City of New York Procede de traitement des troubles respiratoires associes a une lesion de la fibre elastique pulmonaire
WO2001095902A1 (fr) 2000-06-15 2001-12-20 Respiratorius Ab Composition contenant une association d'agonistes et d'antagonistes d'un recepteur
GB0015981D0 (en) 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
FR2812545B1 (fr) 2000-08-03 2003-03-28 Air Liquide Sante Int Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
AU2002246500A1 (en) 2000-10-27 2002-07-30 Emlin Biosciences Thermal vaporizing device for drug delivery
JP2005511477A (ja) * 2001-03-19 2005-04-28 プラエシス ファーマシューティカルズ インコーポレーテッド 持続放出のための医薬調合物
US20030004142A1 (en) * 2001-04-18 2003-01-02 Prior Christopher P. Use of NSAIDs for prevention and treatment of cellular abnormalities of the lung or bronchial pathway
US20070122353A1 (en) * 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7078016B2 (en) * 2001-11-21 2006-07-18 Alexza Pharmaceuticals, Inc. Delivery of caffeine through an inhalation route
WO2002094242A1 (fr) 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Administration de rizatriptan ou de zolmitriptan par voie d'inhalation
US20030032638A1 (en) 2001-05-24 2003-02-13 Kim John J. Delivery of benzodiazepines through an inhalation route
US7498019B2 (en) * 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
US20030138508A1 (en) * 2001-12-18 2003-07-24 Novack Gary D. Method for administering an analgesic
US6805853B2 (en) * 2001-11-09 2004-10-19 Alexza Molecular Delivery Corporation Delivery of diazepam through an inhalation route
US7458374B2 (en) * 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7645442B2 (en) * 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US20080038363A1 (en) * 2001-05-24 2008-02-14 Zaffaroni Alejandro C Aerosol delivery system and uses thereof
NZ529417A (en) * 2001-05-24 2006-11-30 Alexza Pharmaceuticals Inc Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
US20030051728A1 (en) * 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7585493B2 (en) * 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
EP1392262A1 (fr) * 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Administration d'esters medicamenteux par inhalation
US20030118512A1 (en) * 2001-10-30 2003-06-26 Shen William W. Volatilization of a drug from an inclusion complex
US7090830B2 (en) * 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
CA2462576A1 (fr) * 2001-11-21 2003-06-03 Alexza Molecular Delivery Corporation Substrats a cellules ouvertes pour administration de medicaments
US6701922B2 (en) 2001-12-20 2004-03-09 Chrysalis Technologies Incorporated Mouthpiece entrainment airflow control for aerosol generators
US6772756B2 (en) 2002-02-09 2004-08-10 Advanced Inhalation Revolutions Inc. Method and system for vaporization of a substance
AU2003239433A1 (en) * 2002-05-13 2003-11-11 Alexza Molecular Delivery Corporation Delivery of drug amines through an inhalation route
US20060193788A1 (en) * 2002-11-26 2006-08-31 Hale Ron L Acute treatment of headache with phenothiazine antipsychotics
US7074806B2 (en) * 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7485143B2 (en) * 2002-11-15 2009-02-03 Abbott Cardiovascular Systems Inc. Apparatuses and methods for heart valve repair
KR100459905B1 (ko) * 2002-11-21 2004-12-03 삼성전자주식회사 두 개의 잉크챔버 사이에 배치된 히터를 가진 일체형잉크젯 프린트헤드 및 그 제조방법
CA2507158A1 (fr) * 2002-11-26 2004-06-10 Alexza Molecular Delivery Corporation Traitement de la migraine sous antipsychotiques administres par inhalation
US20040105818A1 (en) * 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
CN101371843B (zh) * 2002-11-26 2012-09-26 艾利斯达医药品公司 洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用
US7913688B2 (en) * 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
US20040234914A1 (en) * 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Percussively ignited or electrically ingnited self-contained heating unit and drug-supply unit employing same
ATE470468T1 (de) * 2003-08-04 2010-06-15 Alexza Pharmaceuticals Inc Substrate für eine medikamentenverabreichungsvorrichtung und verfahren zur bereitung
US20050037506A1 (en) * 2003-08-04 2005-02-17 Alexza Molecular Delivery Corporation Methods of determining film thicknesses for an aerosol delivery article
AU2004305518A1 (en) * 2003-12-15 2005-07-07 Alexza Pharmaceuticals, Inc. Treatment of breakthrough pain by drug aerosol inhalation
US20050131739A1 (en) * 2003-12-16 2005-06-16 Alexza Molecular Delivery Corporation Methods for monitoring severity of panic attacks and other rapidly evolving medical events in real time
US7402777B2 (en) * 2004-05-20 2008-07-22 Alexza Pharmaceuticals, Inc. Stable initiator compositions and igniters
US7540286B2 (en) * 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
CA2576961A1 (fr) * 2004-08-12 2006-03-02 Alexza Pharmaceuticals, Inc. Dispositif de distribution de drogue par aerosol integrant des conditionnements thermiques actionnes par percussion
US20060032496A1 (en) * 2004-08-12 2006-02-16 Alexza Molecular Delivery Corporation Inhalation actuated percussive ignition system
WO2006044421A2 (fr) * 2004-10-12 2006-04-27 Alexza Pharmaceuticals, Inc. Administration d'un medicament a action rapide, sans danger pour le systeme cardiovasculaire
CA2645487A1 (fr) * 2006-03-23 2007-10-04 Amgen Inc. Composes d'amide 1-phenylsulfonyl-diaza heterocyclique et leurs utilisations comme modulateurs d'hydroxysteroide deshydrogenases
WO2008080170A1 (fr) 2006-12-22 2008-07-03 Alexza Pharmaceuticals, Inc. Compositions aérosol de médicament mixte
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US20080306285A1 (en) 2007-04-27 2008-12-11 Alexza Pharmaceuticals, Inc. Heat-Labile Prodrugs

Also Published As

Publication number Publication date
DK1389098T3 (da) 2008-11-10
US7115250B2 (en) 2006-10-03
US20040156791A1 (en) 2004-08-12
US7029658B2 (en) 2006-04-18
US20030206869A1 (en) 2003-11-06
US20040228807A1 (en) 2004-11-18
US7078020B2 (en) 2006-07-18
US20030021755A1 (en) 2003-01-30
US20040191181A1 (en) 2004-09-30
CA2446990A1 (fr) 2002-11-28
US20060286043A1 (en) 2006-12-21
US7070764B2 (en) 2006-07-04
US20070014737A1 (en) 2007-01-18
ATE404184T1 (de) 2008-08-15
US7078017B2 (en) 2006-07-18
US20040191185A1 (en) 2004-09-30
US7507398B2 (en) 2009-03-24
EP1390021A1 (fr) 2004-02-25
US7507397B2 (en) 2009-03-24
US20040185007A1 (en) 2004-09-23
US20040161385A1 (en) 2004-08-19
EP1392257A1 (fr) 2004-03-03
ATE462420T1 (de) 2010-04-15
US20030012737A1 (en) 2003-01-16
US20090246147A1 (en) 2009-10-01
DE60220909D1 (de) 2007-08-09
US6797259B2 (en) 2004-09-28
NZ529422A (en) 2006-11-30
US7070762B2 (en) 2006-07-04
BE2013C054I2 (fr) 2021-07-19
US20040191182A1 (en) 2004-09-30
EP1389099A1 (fr) 2004-02-18
US20040185002A1 (en) 2004-09-23
US7169378B2 (en) 2007-01-30
EP1389097B1 (fr) 2008-08-13
US6783753B2 (en) 2004-08-31
US7442368B2 (en) 2008-10-28
US7465435B2 (en) 2008-12-16
EP1392259A2 (fr) 2004-03-03
US6855310B2 (en) 2005-02-15
US7468179B2 (en) 2008-12-23
US7465436B2 (en) 2008-12-16
EP1389096A1 (fr) 2004-02-18
US20040184998A1 (en) 2004-09-23
US20040185005A1 (en) 2004-09-23
US7008616B2 (en) 2006-03-07
MXPA03010702A (es) 2004-03-02
CA2447166C (fr) 2009-12-22
US20030007933A1 (en) 2003-01-09
US6716415B2 (en) 2004-04-06
ATE462421T1 (de) 2010-04-15
US6737042B2 (en) 2004-05-18
NZ529416A (en) 2006-11-30
NZ529421A (en) 2006-11-30
US6780400B2 (en) 2004-08-24
US7008615B2 (en) 2006-03-07
EP1389097A1 (fr) 2004-02-18
US20070178052A1 (en) 2007-08-02
US7067114B2 (en) 2006-06-27
US20030007934A1 (en) 2003-01-09
US7052680B2 (en) 2006-05-30
PL363997A1 (en) 2004-11-29
US20030017114A1 (en) 2003-01-23
EP1389094B1 (fr) 2008-09-03
EP1392257B1 (fr) 2008-07-16
US20060246011A1 (en) 2006-11-02
US7087216B2 (en) 2006-08-08
US20040185008A1 (en) 2004-09-23
US6740309B2 (en) 2004-05-25
US20030017116A1 (en) 2003-01-23
JP2005503425A (ja) 2005-02-03
US20040202617A1 (en) 2004-10-14
EP1392261B1 (fr) 2008-12-31
NZ529418A (en) 2006-11-30
US7465437B2 (en) 2008-12-16
US20060257329A1 (en) 2006-11-16
US20030012740A1 (en) 2003-01-16
US20040156790A1 (en) 2004-08-12
EP1987823A1 (fr) 2008-11-05
JP2010270138A (ja) 2010-12-02
US6805854B2 (en) 2004-10-19
US7014840B2 (en) 2006-03-21
US20060251587A1 (en) 2006-11-09
US20030017115A1 (en) 2003-01-23
US20060233719A1 (en) 2006-10-19
US7063830B2 (en) 2006-06-20
ATE406878T1 (de) 2008-09-15
US20040185001A1 (en) 2004-09-23
WO2002094236A1 (fr) 2002-11-28
ATE401064T1 (de) 2008-08-15
JP2004531556A (ja) 2004-10-14
US20040185004A1 (en) 2004-09-23
US20040191179A1 (en) 2004-09-30
US7048909B2 (en) 2006-05-23
PT1389098E (pt) 2008-11-14
US20030005924A1 (en) 2003-01-09
US20030017118A1 (en) 2003-01-23
US7988952B2 (en) 2011-08-02
CA2446904A1 (fr) 2003-04-03
US7005122B2 (en) 2006-02-28
WO2002094236A9 (fr) 2006-11-16
EP1390021B1 (fr) 2008-12-24
US6740308B2 (en) 2004-05-25
US7449175B2 (en) 2008-11-11
AU2002303833B2 (en) 2007-11-29
ATE418330T1 (de) 2009-01-15
CA2446917A1 (fr) 2002-11-28
US7078018B2 (en) 2006-07-18
US7022312B2 (en) 2006-04-04
US7485285B2 (en) 2009-02-03
US7018620B2 (en) 2006-03-28
JP2004532859A (ja) 2004-10-28
ES2324023T3 (es) 2009-07-29
US20040127481A1 (en) 2004-07-01
US7108847B2 (en) 2006-09-19
US20060153779A1 (en) 2006-07-13
US20060251588A1 (en) 2006-11-09
NZ529420A (en) 2006-11-30
US20060246012A1 (en) 2006-11-02
CA2446916C (fr) 2009-12-22
JP2004532860A (ja) 2004-10-28
ES2341392T3 (es) 2010-06-18
US20040126326A1 (en) 2004-07-01
US7078019B2 (en) 2006-07-18
PT1389096E (pt) 2009-06-12
US20040126328A1 (en) 2004-07-01
US20030017119A1 (en) 2003-01-23
CA2446916A1 (fr) 2002-11-28
EP1389098A1 (fr) 2004-02-18
ATE404173T1 (de) 2008-08-15
US20040184999A1 (en) 2004-09-23
JP2004536805A (ja) 2004-12-09
JP4578772B2 (ja) 2010-11-10
CA2447521A1 (fr) 2002-11-28
CA2447099C (fr) 2010-01-26
US7005121B2 (en) 2006-02-28
US7060254B2 (en) 2006-06-13
US7449172B2 (en) 2008-11-11
US6740307B2 (en) 2004-05-25
EP1392259B1 (fr) 2007-06-27
US7087217B2 (en) 2006-08-08
EP1389095A1 (fr) 2004-02-18
US20040156789A1 (en) 2004-08-12
US7449174B2 (en) 2008-11-11
US6814954B2 (en) 2004-11-09
US6780399B2 (en) 2004-08-24
US6814955B2 (en) 2004-11-09
ES2312571T3 (es) 2009-03-01
US6884408B2 (en) 2005-04-26
CA2447521C (fr) 2009-12-29
US7445768B2 (en) 2008-11-04
US7070765B2 (en) 2006-07-04
US20060269487A1 (en) 2006-11-30
US20040191183A1 (en) 2004-09-30
CA2446917C (fr) 2009-12-22
US7052679B2 (en) 2006-05-30
CA2446990C (fr) 2009-12-22
US20030000518A1 (en) 2003-01-02
US20030017120A1 (en) 2003-01-23
US20060280692A1 (en) 2006-12-14
US20040191180A1 (en) 2004-09-30
ATE365548T1 (de) 2007-07-15
ATE418971T1 (de) 2009-01-15
US20060286042A1 (en) 2006-12-21
PL364002A1 (en) 2004-11-29
US20040170569A1 (en) 2004-09-02
US20080175796A1 (en) 2008-07-24
US20040126329A1 (en) 2004-07-01
US7601337B2 (en) 2009-10-13
US20030015190A1 (en) 2003-01-23
EP1392262A1 (fr) 2004-03-03
EP1392264B1 (fr) 2008-07-16
EP1987823B1 (fr) 2010-03-31
US20040184997A1 (en) 2004-09-23
US20060177382A1 (en) 2006-08-10
EP1392261A2 (fr) 2004-03-03
US20060239936A1 (en) 2006-10-26
US7070761B2 (en) 2006-07-04
EP1389098B1 (fr) 2008-08-13
US7063831B2 (en) 2006-06-20
US7094392B2 (en) 2006-08-22
US6716416B2 (en) 2004-04-06
DE60235852D1 (de) 2010-05-12
US20030017117A1 (en) 2003-01-23
US20050075273A1 (en) 2005-04-07
ATE425746T1 (de) 2009-04-15
US7524484B2 (en) 2009-04-28
US7070766B2 (en) 2006-07-04
JP4578773B2 (ja) 2010-11-10
NZ529419A (en) 2006-11-30
US20040185000A1 (en) 2004-09-23
US7510702B2 (en) 2009-03-31
ES2341594T3 (es) 2010-06-22
US20040170573A1 (en) 2004-09-02
US20040156788A1 (en) 2004-08-12
JP5629151B2 (ja) 2014-11-19
US20030021754A1 (en) 2003-01-30
AU2002310015B2 (en) 2008-09-04
US20030021753A1 (en) 2003-01-30
US6716417B2 (en) 2004-04-06
US20040191184A1 (en) 2004-09-30
US6743415B2 (en) 2004-06-01
DE60228232D1 (de) 2008-09-25
US20030015189A1 (en) 2003-01-23
US6994843B2 (en) 2006-02-07
US20040186130A1 (en) 2004-09-23
PL363996A1 (en) 2004-11-29
US6803031B2 (en) 2004-10-12
ES2311607T3 (es) 2009-02-16
EP1392264A1 (fr) 2004-03-03
EP1990046A1 (fr) 2008-11-12
US7063832B2 (en) 2006-06-20
US7070763B2 (en) 2006-07-04
DE60220909T2 (de) 2008-02-28
US7045118B2 (en) 2006-05-16
US20060216244A1 (en) 2006-09-28
US7491047B2 (en) 2009-02-17
US20040185006A1 (en) 2004-09-23
US8173107B2 (en) 2012-05-08
EP1990046B1 (fr) 2010-03-31
CA2447099A1 (fr) 2002-11-28
US20050089479A1 (en) 2005-04-28
US20060216243A1 (en) 2006-09-28
EP1389096B1 (fr) 2009-03-18
US7011820B2 (en) 2006-03-14
MXPA03010703A (es) 2004-07-01
AU2002314784A1 (en) 2002-12-03
JP2004535403A (ja) 2004-11-25
CA2447166A1 (fr) 2002-11-28
US20040184996A1 (en) 2004-09-23
US6776978B2 (en) 2004-08-17
DE60235851D1 (de) 2010-05-12
US7033575B2 (en) 2006-04-25
ATE401063T1 (de) 2008-08-15
US20040167228A1 (en) 2004-08-26
US7014841B2 (en) 2006-03-21
EP1389096B9 (fr) 2009-08-26
EP1389094A1 (fr) 2004-02-18
US20040126327A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
FR13C0051I1 (fr) Administration d'antipsychotiques par inhalation
WO2002094218A3 (fr) Administration par voie pulmonaire d'alprazolam, d'estazolam, de midazolam ou de triazolam
WO2002094244A3 (fr) Administration de benzodiazepines via une voie pulmonaire
HUS1900056I1 (hu) Légzési rendellenességek kezelésére alkalmas, glikopirrolát tartalmú száraz porkészítményt tartalmazó inhaláló készülék és alkalmazása
NZ507151A (en) Pulmonary and nasal delivery of raloxifene
ATE271383T1 (de) Pulverformulierung zur inhalation
GB0127989D0 (en) Medicament dispensing system
MY108564A (en) Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
ATE357222T1 (de) Hochwirksame verabreichung eines aerosols mit hoher therapeutischer masse
CY1110379T1 (el) Συνθεση που περιλαμβανει φορμοτερολη και ενα γλυκοκορτικοστεροειδες
ATE545442T1 (de) Medizinische vorrichtung zur inhalation von aerosolisiertem arzneimittel mit heliox
IL173371A0 (en) Medicaments for inhalation comprising betamimetics and an anticholinergic
NO20021231D0 (no) Kombinasjons munnstykke for inhaleringsterapianordninger til bruk for oksygenavhengige pasienter
SG137859A1 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
WO2002094219A3 (fr) Administration par voie pulmonaire de medicaments contre les troubles de l'erection
WO2002094216A3 (fr) Administration de stimulants par voie d'inhalation
MXPA04007294A (es) Composicion para inhalacion.
MXPA04002401A (es) Nuevos medicamentos para inhalacion.
TWI256388B (en) Pharmaceutical combination
WO2003094694A3 (fr) Appareil a main d'inhalotherapie et procede d'utilisation